The retinoblastoma (RB) gene specifies a nuclear phosphoprotein (pRb 105), which is a prototype tumor suppressor inactivated in a variety of human tumors. Recent studies suggest that RB is also involved in embryonic development of murine central nervous and hematopoietic systems. We have investigated RB expression and function in human adult hematopoiesis-i.e., in liquid suspension culture of purified quiescent hematopoietic progenitor cells (HPCs) induced by growth factor stimulus to proliferation and unilineage differentiation/maturation through the erythroid or granulocytic lineage. In the initial HPC differentiation stages, the RB gene is gradually induced at the mRNA and protein level in both erythroid and granulopoietic cultures. In late HPC differentiation and then precursor maturation, RB gene expression is sustained in the erythroid lineage, whereas it is sharply downmodulated in the granulocytic series. Functional studies were performed by treatment of HPC differentiation culture with phosphorothioate antisense oligomer targeting Rb mRNA; coherent with the expression pattern, oligomer treatment of late HPCs causes a dose-dependent and selective inhibition of erythroid colony formation. These observations suggest that the RB gene plays an erythroid-and stagespecific functional role in normal adult hematopoiesis, particularly at the level of late erythroid HPCs.
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Hematopoiesis is a multistep cell proliferation and differentiation process, which is sustained by a pool of hematopoietic stem cells (HSCs) (1) (2) (3) . HSCs are capable of extensive self-renewal and feed into lineage-committed hematopoietic progenitor cells (HPCs). The HPCs are functionally defined as colony-or burst-forming units (CFUs, BFUs)-i.e., HPCs of the erythroid (BFU-E, CFU-E), granulomonocytic (CFU-GM, CFU-G, CFU-M) lineage and multipotent HPCs for erythroid, granulomonocytic, and megakaryocytic series (CFU-GEMM). Early HPCs (BFU-E, CFU-GM, CFU-GEMM) are stimulated by multilineage hematopoietic growth factors HGFs-i.e., interleukin 3 (IL-3), GM colonystimulating factor (GM-CSF)-while late HPCs (CFU-E, CFU-G, CFU-M) are stimulated by unilineage HGFs [erythropoietin (Ep), G-CSF, and M-CSF, respectively]. HPCs differentiate into morphologically recognizable precursors that mature to terminal elements circulating in peripheral blood (PB). Early-late HPCs are also present in PB (3, 4) .
The retinoblastoma (RB) gene is a tumor suppressor gene; inactivation of both RB loci results in retinoblastoma and other adult tumors (5) . The product of the RB gene is a nuclear phosphoprotein (pRb; 105 kDa) that is ubiquitously expressed in vertebrates (6) . The functional properties of pRb relate to its phosphorylation state, which is cell cycle dependent (7, 8) .
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. pRb is un-or hypophosphorylated through the early G1 stage, reaches different levels of hyperphosphorylation from late G1 through mitosis, and is again hypophosphorylated after the end of mitosis. The phosphorylation state of pRb correlates with its growth-suppressive potential, the hypophosphorylated form being the growth suppressive one; introduction of unphosphorylated pRb into cells inhibits cell cycle progression (9) and reverts the tumor phenotype in RB-cells (10) . Furthermore, the unphosphorylated form of pRb binds oncoproteins of DNA tumor viruses-e.g., adenovirus ElA, simian virus 40 large T antigen, and human papillomavirus E6 (11) (12) (13) . The ability of these oncoproteins to immortalize mammalian cells correlates with their capacity to complex with unphosphorylated pRb, thus suggesting that their growthpromoting activity is mediated by pRb inactivation. In human cells, pRb binds to a number of nuclear proteins (14) , including the transcription factor E2F (15, 16) ; upon pRb hyperphosphorylation, E2F is released and transactivates a variety of cell cycle-related genes (17, 18) .
Recent evidence strongly suggests a role for pRb in ontogenetic development of the hematopoietic system. Mice rendered RB by gene targeting of embryonic stem cells die in early gestation because of gross defects of both central nervous and hematopoietic systems (19) (20) (21) . The latter abnormalities involve reduced formation of hepatic blood islands coupled with a marked increase of immature nucleated erythroid cells; in line with these observations, in vitro clonogenetic studies on embryonic liver RB-cells showed a normal number of late erythroid HPCs (CFU-E), which are hampered in their differentiation/maturation capacity (19) (20) (21) . However, these observations do not provide insight into the role of RB in adult hematopoiesis, which is still unknown.
We have investigated RB gene expression and function in human adult HPCs induced to proliferate, differentiate, and mature through terminal stages along the erythroid or granulopoietic lineage.
MATERIALS AND METHODS
Hematopoietic Growth Factors and Cell Culture Medium. Recombinant human growth factors were obtained from standard commercial sources (22) (23) (24) . Iscove's medium (IMDM; GIBCO) was freshly prepared on a weekly basis.
Abbreviations: HSC, hematopoietic stem cell; HPC, hematopoietic progenitor cell; BFU-E, erythroid burst-forming unit; CFU-E, erythroid colony-forming unit; CFU-GM, granulomonocytic CFU; CFU-GEMM, erythroid, granulomonocytic, and megakaryocytic CFU; HGF, hematopoietic growth factor; IL-3, interleukin 3; GM-CSF, GM colony-stimulating factor; Ep, erythropoietin; PB, peripheral blood; Adult PB HPC Purification and Clonogenetic Assay. HPCs were purified from the PB buffy coat according to the method in ref. 22 modified as described (23, 24) . Purified HPC clonogenetic cultures with or without fetal calf serum (FCS+ or FCS-) were prepared as described (23) (24) (25) .
HPC Erythroid and Granulopoietic Liquid Suspension Culture.
Step IIIP HPCs were seeded (5 x 104 cells per ml) and grown in liquid FCS-medium (see ref. 25 ) supplemented with HGFs-i.e., in erythropoietic culture, very low doses of IL-3 (0.01 unit/ml) and GM-CSF (0.001 ng) and a saturating level of Ep (3 units); in granulopoietic culture, low amounts of IL-3 (1 unit) and GM-CSF (0.1 ng) and saturating amounts of w~~~~~~~~~~~~~~0 0I G-CSF (10 ng) as described (24) . Cells were periodically counted and analyzed for morphology, membrane phenotype, and RB gene expression.
Immunofluorescence and Western Blot Analysis. Indirect immunofluorescence was performed as described (24) (23, 24, (28) (29) (30) . cDNAs were normalized by the p32-microglobulin gene (29) . RT-RNA from CEM cell line was used as an internal positive control. Rb primers and probe were as follows: 5' primer, 5'-GCTATGTCAAGACTGTTG-3'; 3' primer, 5'-TTGAGCAACATGGGAGGT-3'; internal probe, 5'-TTGGTGCTAAAAGTTTCTTGGATC-3' (6). The amplification procedure included denaturation at 95°C for 30 sec, annealing at 54°C for 30 sec, and extension at 72°C during 40 PCR cycles-i.e., within the range of linear amplification. Methodology for c-myb mRNA RT-PCR has been reported (31) .
HPC Oligomer Treatment and Clonogenetic Assay. Treatment was as described (24, (29) (30) (31) .
Oligomers. The following phosphorothioate oligodeoxynucleotides were used: antisense Rb (a-Rb), 5'-GTGAACGA-CATCTCATCTAGG-3' complementary to 21 nucleotides starting from 465-to 485-bp Rb mRNA coding sequence (6) ; scrambled a-Rb, 5'-TACTGGCJAAGCCTAGCATGA-3'.
Oligomer treatment. Early HPC treatment:
Step IIIP cells (5 X 103 cells per ml) in standard erythroid or granulopoietic liquid-phase culture (see above) were supplemented with (i) the standard erythroid-or granulopoietic-specific HGF combination (see above) and (ii) a-Rb or scrambled a-Rb (25, 50, or 100 ,ug/ml). In some experiments, the erythroid or granulopoietic liquid-phase culture was supplemented with saturating HGF stimulus (i.e., IL-3 at 100 units/ml and GM-CSF at 10 ng with or without 3 units of Ep) and a-Rb or scrambled a-Rb (25, 50, or 100 ,ug). Cells were incubated from day 0 through day 1; mock-treated controls were included. Cells were then plated in FCS-clonogenetic culture (see above) supplemented with the same HGF combination used in the liquid-phase culture. Late HPC treatment:
Step IIIP cells were diluted in standard liquid-phase erythroid and granulopoietic cultures. At day 6 a-Rb or scrambled a-Rb oligomer (25, 50, or 100 ,ug) was added; mock-treated controls were included. After 24-48 h of incubation, cells from erythroid or granulopoietic culture were plated in FCS-clonogenetic culture with either the erythroid-or granulopoietic-specific HGF combination or the erythroid or granulopoietic saturating HGF Fig. 1 ). In the first week of culture, the HPCs are gradually induced into cycling; amplification of their number is associated with progressive differentiation along the granulopoietic pathway, as shown by the decrease of (i) the size of granulocytic colonies generated by HPCs, (ii) CD34 antigen expression, and (iii) percent blast number ( Fig. 1 ; data not shown; see also ref. 24 ). In the second week, the differentiated granulopoietic precursors show increasing expression of lineage-specific markers (e.g., CD15), coupled with a converse drop of CD34+ cell frequency to undetectable levels (data not shown); morphology analysis shows a gradual wave of differentiation along the granulopoietic pathway to terminal differentiation ( Fig. 1 Expression of Rb mRNA in Erythroid or Granulopoietic HPC Cultures. RNA samples were generated from liquid suspension culture at sequential days (representative results are shown in Fig. 2 ). Rb mRNA, barely expressed in the starting quiescent HPCs, is rapidly induced and expressed through the first culture week in both differentiation systems. In the second week, we observed that (i) in the erythroid pathway high-level Rb mRNA expression is sustained through terminal maturation; (ii) in the granulopoietic pathway initial Rb mRNA expression is downregulated at the stage of early granulopoietic precursors (days 8-10 of culture; see Fig. 1 Lower) and is apparently abolished through terminal maturation (days 14 and 17). As a control, c-myb mRNA is induced upon HGF stimulus and expressed through advanced erythroid and granulocytic maturation (Fig. 2) .
Expression of pRb in Differentiating HPC Culture. In parallel we evaluated (i) pRb expression by indirect immunofluorescence analysis and (ii) pRb expression and phosphorylation level by Western blot. Immunofluorescence analysis: Day 0 quiescent HPCs do not exhibit detectable pRb (Fig. 3A) . The initial differentiation of HPCs along the erythroid or granulopoietic pathway is associated with the induction of pRb. In the second culture week, pRb expression is still elevated in differentiating erythroblasts but abruptly declines and almost completely disappears in granulopoietic precursors (Fig. 3A andB) . Western blot analysis (Fig. 3C) : In day 0 HPCs pRb is expressed at a low level in its fast-migrating, hypophosphorylated state. At day 6, induction of HPC proliferation and differentiation induces a sharp increase of pRb levels, coupled with the appearance of the hyperphosphorylated, slowmigrating form(s) of pRb in both erythroid and granulopoietic cultures. At day 12, the pRb level is still elevated in erythroblasts, whereas it is sharply downmodulated in granulopoietic precursors.
Effect of a-Rb Oligonucleotide in HPC Differentiation Culture. In a first set of experiments, purified HPCs were seeded in liquid-phase erythroid or granulopoietic culture; [6] [7] [8] . Effect on HPC erythroid (E) or granulocytic (G) colony formation in semisolid culture induced by erythroid-or granulopoietic-specific HGF stimulus, as applied in liquid-phase culture, is shown. Mock-treated controls are also presented. Mean SEM values from three independent experiments, each performed in triplicate dishes, are shown. *, P < 0.05; **, P < 0.01 when compared to corresponding "scrambled" group. (Inset) Representative RT-PCR experiment showing the effect of 50-and 100-,ug dosages of either a-Rb (a) or scrambled a-Rb (S) oligomers on Rb and 132-microglobulin (132m) mRNA expression; mock-treated controls (C) are also presented. alternatively, they were seeded in the same liquid-phase medium supplemented with saturating levels of IL-3 and GM-CSF with or without Ep. All cultures were treated with a-Rb or scrambled a-Rb oligomer from day 0 through day 1. HPCs were then plated in semisolid culture supplemented with the same HGF combination used in the corresponding liquid culture. Addition of a-Rb had no influence on erythroid colony formation and only a slight, barely significant effect on the number of CFU-GM colonies upon saturating IL-3 and GM-CSF treatment (data not shown). In a second set of experiments purified HPCs were first grown for 6 days in liquid suspension culture under either erythroid or granulopoietic differentiation conditions, treated with a-Rb or scrambled oligomers from day 6 through day 7 or 8, and finally plated in semisolid cultures supplemented with either the same HGF stimuli used in liquid suspension culture (Fig. 4) 
DISCUSSION
The discrete molecular events underlying early hematopoiesis are still poorly understood, primarily because of the extreme rarity of HPCs and HSCs in human bone marrow (1) and PB (4, 22) . Therefore, we have developed methodology for (i) HPC purification and (ii) unilineage differentiation in liquidphase culture. (i) The purification methodology (22) has been recently improved to allow both stringent purification and abundant recovery of HPCs from adult PB (3, 23, 24, 29) . The purified step IIIP HPCs (CFU-GEMM, BFU-E, and CFU-GM) are a homogenous population of highly undifferentiated HPCs (3, (22) (23) (24) 28) , as compared to primitive bone marrow HPCs (32) (33) (34) (35) (23, 24, 28, 29) .
In HPC erythroid and granulopoietic cultures the RB gene is modulated at both mRNA and protein levels. In the freshly purified, largely quiescent HPCs Rb mRNA and protein is detected at a low level by RT-PCR and Western blot (the lack of pRb by immunofluorescence may be attributed to the higher threshold of detection). After HGF-induced HPC proliferation, the RB gene is gradually activated, as in phytohemagglutinin-activated T cells (36) . The pRb, while hypophosphorylated in the quiescent HPCs, becomes prevailingly hyperphosphorylated in the proliferating HPCs, thus in line with the phosphorylation pattern observed in other cell types in quiescent and cycling status (7, 8) . The modulation of RB expression during HPC differentiation and precursor maturation is typically biphasic: (i) during HPC differentiation Rb mRNA and protein are induced in both erythroid and granulopoietic cultures and (ii) during precursor maturation sustained expression of Rb mRNA and protein in the erythroid series contrasts with marked downmodulation in the granulopoietic pathway.
Functional experiments were based on Rb mRNA suppression by antisense oligomers. Addition of a-Rb on early HPCsi.e., at day 0-1 of culture-exerted no effect on erythroid colony formation but slightly enhanced CFU-GM clonogenetic capacity in the presence of an elevated level of IL-3 and GM-CSF, thus in line with a previous report (37) ; the latter phenomenon may suggest that Rb mRNA inhibition in quiescent CFU-GM mildly facilitates their response to a saturating growth factor stimulus. More important, treatment with a-Rb of late HPCs-i.e., addition at days 6-8 of erythroid or granulopoietic culture-induces a dose-dependent inhibition of erythroid but not granulopoietic colony formation. These results indicate that RB plays a lineage-restricted role in late erythroid HPC differentiation.
Altogether, these expression/function results consistently indicate that the RB gene is modulated in adult hematopoiesis according to a lineage-and stage-specific pattern with peak pRB expression and a key functional role at the level of late erythroid HPCs.
The developmental defect of hematopoiesis in RB-mice may be explained by the ability of pRb to associate with and potentiate the activity of erythroid-specific transcription factors (20) . Along these lines, biochemical association of pRb with products of the MyoD gene family in skeletal muscle cells is essential for terminal differentiation (38 (40) . In view of these striking similarities between RB and GATA-1 expression/function in erythropoiesis, the hypothesis may be considered that RB and GATA-1 proteins directly or indirectly interact at biochemical and/or functional levels, particularly in late erythroid HPCs.
